Drug Trial Radar · NCT07643766
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Jun 29, 2026
Primary completion
Dec 2027
Study completion May 2028
Sponsor
- Lead sponsor
- Enveda TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This double-blind, placebo-controlled study is designed to evaluate the safety and efficacy of ENV-294 in adults with moderate-to-severe atopic dermatitis (AD). The study will compare three dose levels of ENV-294 with placebo administered for 12 weeks. Participants will undergo screening, receive study treatment, and complete scheduled assessments of disease activity, symptoms, quality of life, safety, pharmacokinetics, and biomarker responses.
Conditions
- Atopic Dermatitis
Interventions
ENV-294Drug
ENV-294 is an orally administered investigational drug supplied as tablets. Participants receive ENV-294 once daily by mouth for 12 weeks.
PlaceboOther
Matching oral tablet that does not contain active drug. Administered once daily by mouth for 12 weeks under the same conditions as the investigational product.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in Eczema Area and Severity Index (EASI) scoreTime frame: Baseline to Week 12
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Enveda Investigative Site
Encinitas, California · Recruiting
Enveda Investigative Site
Los Angeles, California · Recruiting
Enveda Investigative Site
Northridge, California · Recruiting
Enveda Investigative Site
Boca Raton, Florida · Recruiting
Enveda Investigative Site
Indianapolis, Indiana · Recruiting
Enveda Investigative Site
Plainfield, Indiana · Recruiting
Enveda Investigative Site
Dallas, Texas · Recruiting
Enveda Investigative Site
San Antonio, Texas · Recruiting
Enveda Investigative Site
Sugar Land, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.